Thursday, March 09, 2023 12:39:01 PM
Intersting take on algernon s efforts..
Failure never smells good..
They picked their battle and lost..
The math is not pretty..
I can’t argue that..
Moreau will have to make the case
for neuroscience value.. to algernon shareholders..
I would prefer everything stay in Algernon..the public entity..
Plans change.. Giving Chris some
room to make this an exciting play ..
The DMT may be exciting enough without doing private neuroscience. For those of a suspicious mind .. it could look as though
The valuable assets are being moved out of the public asset into private hands..
That would not go over well ..
I don’t think that is Chris’s goal or effort
FEATURED Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • May 16, 2024 8:13 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM
HealthLynked Corp Announces First Quarter 2024 Results: Achieves 8% Revenue Growth Over Last Quarter • HLYK • May 16, 2024 8:00 AM
Integrated Ventures Files Q3/2024 With Mining Revenues Of $1,983,250 And Positive Earnings Of $0.05 Cents Per Share • INTV • May 15, 2024 10:30 AM
Swifty Global Announces Impressive Financial Results for Q1 2024 • DRCR • May 15, 2024 10:25 AM